Capitolis Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$9.54M 19
2022
Q3
$9.54M Buy
100,000
+97,309
+3,616% +$9.63M 0.68% 40
2022
Q2
$249K Hold
2,691
0.01% 100
2022
Q1
$272K Sell
2,691
-35,685
-93% -$3.75M 0.01% 117
2021
Q4
$3.96M Buy
38,376
+16,685
+77% +$1.54M 0.02% 339
2021
Q3
$1.83M Sell
21,691
-20,955
-49% -$1.76M 0.02% 299
2021
Q2
$3.56M Buy
42,646
+21,691
+104% +$1.78M 0.04% 240
2021
Q1
$1.58M Sell
20,955
-69,220
-77% -$5.04M 0.03% 268
2020
Q4
$6.16M Buy
+90,175
New +$5.87M 0.1% 190

Other funds holding CVS

Capitolis Advisors's CVS Position: Q4 2022 in Review

Capitolis Advisors sold out of CVS Health (CVS) in Q4 2022, closing a stake of 100,000 shares — an estimated $9.54M sold.

Capitolis Advisors first reported a position in CVS in Q4 2020 and held it in 8 quarters. The position peaked at $9.54M in Q3 2022. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Capitolis Advisors reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Capitolis Advisors sold 100,000 CVS Health shares in Q4 2022, an estimated $9.54M.
  • Capitolis Advisors first reported a position in CVS Health in Q4 2020 and held it in 8 quarters.
  • Capitolis Advisors's CVS Health position peaked at $9.54M in Q3 2022.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Capitolis Advisors's 13F filing for Q4 2022.